are glp-1 drugs covered by insurance Perspectives from employers on the costs and issues associated with covering agonists for weight loss How GLP-1 Medication for Weight

Regarding this class of molecules, studies in rats have led to mixed results

Novo Nordisk/Septerna (May 2025) Novo committed $2.2B to partner with Septerna (US startup) on an oral obesity drug candidate ( [30] )

An annual survey from the health policy research organization KFF recently found that half of the remaining state Medicaid programs are considering covering the drugs, but that the high costs are still prohibitive for most despite federal matches and rebate programs with drug manufacturers

The availability of this pill could make weight-loss treatment more accessible to a large number of Americans who have avoided injectable options due to expense, discomfort with needles or rigid dosing rules

Semaglutide on the other hand displays limited efficacy in crossing the BBB, but despite this fact it was proven to access the brainstem, septal nucleus and hypothalamus [42]

Exenatide readily enters the brain when injected intravenously into mice (102)